ILF2 Antikörper (AA 1-390)
Kurzübersicht für ILF2 Antikörper (AA 1-390) (ABIN517145)
Target
Alle ILF2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-390
-
Verwendungszweck
- Mouse polyclonal antibody raised against a full-length human ILF2 protein.
-
Sequenz
- MRGDRGRGRG GRFGSRGGPG GGFRPFVPHI PFDFYLCEMA FPRVKPAPDE TSFSEALLKR NQDLAPNSAE QASILSLVTK INNVIDNLIV APGTFEVQIE EVRQVGSYKK GTMTTGHNVA DLVVILKILP TLEAVAALGN KVVESLRAQD PSEVLTMLTN ETGFEISSSD ATVKILITTV PPNLRKLDPE LHLDIKVLQS ALAAIRHARW FEENASQSTV KVLIRLLKDL RIRFPGFEPL TPWILDLLGH YAVMNNPTRQ PLALNVAYRR CLQILAAGLF LPGSVGITDP CESGNFRVHT VMTLEQQDMV CYTAQTLVRI LSHGGFRKIL GQEGDASYLA SEISTWDGVI VTPSEKAYEK PPEKKEGEEE EENTEEPPQG EEEESMETQE
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody reactive against mammalian transfected lysate.
-
Immunogen
- ILF2 (NP_004506.2, 1 a.a. ~ 390 a.a) full-length human protein.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models." in: Biotechnology and bioengineering, Vol. 111, Issue 9, pp. 1853-63, (2014) (PubMed).
-
: "Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models." in: Biotechnology and bioengineering, Vol. 111, Issue 9, pp. 1853-63, (2014) (PubMed).
-
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
-
Andere Bezeichnung
- ILF2
-
Hintergrund
-
Full Gene Name: interleukin enhancer binding factor 2, 45 kDa
Synonyms: MGC8391,NF45,PRO3063 -
Gen-ID
- 3608
-
NCBI Accession
- NM_004515
Target
-